|
Dr.Ted Meigs,
Assistant Professor, Ph.D., Stanford
University.
Dr. Meigs' research addresses the broad question
of how cells in the human body communicate with
each other. Cells have the ability to bind chemical
messages, or "signals," on the outer surface of the
cell, and transmit this information to the cell
interior through a series of interesting proteins
that physically interact and pass along a
particular signal. Dr. Meigs is particularly
interested in studying and characterizing the
signaling pathways that involve a heterotrimeric
GTP-binding protein termed G12, which is known to
participate in cancer progression and embryo
development. His primary research goals are to
identify the structural regions of G12 that are
essential for binding to other signal-transmitting
proteins. Also, he is interested in deciphering the
mechanisms by which G12 affects the function of
cell-surface proteins termed cadherins, that are
important for adhesion between adjacent cells of
the body.
Dr. Meigs obtained his B.S. from Western
Carolina University in 1990, and his Ph.D. from
Stanford University in 1996, where he studied the
cellular mechanisms that control cholesterol
metabolism. More recently, he conducted
post-doctoral studies of cellular signal
transduction at Duke University Medical Center. He
is maintaining a collaboration with Dr. Pat Casey,
Director of the Center for Chemical Biology at Duke
University, with Dr. Meigs serving as
Co-Investigator for a grant funded by the National
Institutes of Health.
|

|